Bill Text: MN SF2989 | 2013-2014 | 88th Legislature | Introduced
Bill Title: Resolution memorializing the Congress of the United States to direct the Food and Drug Administration (FDA) to conduct trials for medical marijuana research
Spectrum: Partisan Bill (Republican 5-0)
Status: (Introduced - Dead) 2014-05-15 - Referred to Health, Human Services and Housing [SF2989 Detail]
Download: Minnesota-2013-SF2989-Introduced.html
1.1A resolution
1.2memorializing the Congress of the United States to direct the United States Food and
1.3Drug Administration to conduct trials for medical marijuana research.
1.4WHEREAS, there is a need for additional comprehensive and well-controlled studies on
1.5the effectiveness of using marijuana and related cannabinoids to treat patients who have serious
1.6conditions; and
1.7WHEREAS, preclinical, anecdotal, and controlled evidence suggests the possible efficacy
1.8of marijuana and related cannabinoid treatment, and that the application of such evidence could
1.9enhance the understanding and treatment of disease; and
1.10WHEREAS, marijuana is currently classified by the United States Drug Enforcement
1.11Administration as a federal Schedule I controlled substance, thereby restricting medical use
1.12research; and
1.13WHEREAS, it is important to enable researchers to conduct more clinical and public health
1.14research with the purpose of developing cannabinoid-based medicines, specifically allowing for
1.15randomized clinical trials and alternative delivery methods; NOW, THEREFORE,
1.16BE IT RESOLVED by the Legislature of the State of Minnesota that it urges the President
1.17and the Congress of the United States to direct the United States Food and Drug Administration to
1.18approve randomized clinical trials for medicinal use of marijuana.
1.19BE IT FURTHER RESOLVED that the Secretary of State of the State of Minnesota is
1.20directed to prepare copies of this memorial and transmit them to the President of the United
1.21States, the President and the Secretary of the United States Senate, the Speaker and the Clerk of
1.22the United States House of Representatives, the chair of the United States Senate Committee on
2.1Finance, the chair of the United States House Committee on Ways and Means, and Minnesota's
2.2Senators and Representatives in Congress.
1.2memorializing the Congress of the United States to direct the United States Food and
1.3Drug Administration to conduct trials for medical marijuana research.
1.4WHEREAS, there is a need for additional comprehensive and well-controlled studies on
1.5the effectiveness of using marijuana and related cannabinoids to treat patients who have serious
1.6conditions; and
1.7WHEREAS, preclinical, anecdotal, and controlled evidence suggests the possible efficacy
1.8of marijuana and related cannabinoid treatment, and that the application of such evidence could
1.9enhance the understanding and treatment of disease; and
1.10WHEREAS, marijuana is currently classified by the United States Drug Enforcement
1.11Administration as a federal Schedule I controlled substance, thereby restricting medical use
1.12research; and
1.13WHEREAS, it is important to enable researchers to conduct more clinical and public health
1.14research with the purpose of developing cannabinoid-based medicines, specifically allowing for
1.15randomized clinical trials and alternative delivery methods; NOW, THEREFORE,
1.16BE IT RESOLVED by the Legislature of the State of Minnesota that it urges the President
1.17and the Congress of the United States to direct the United States Food and Drug Administration to
1.18approve randomized clinical trials for medicinal use of marijuana.
1.19BE IT FURTHER RESOLVED that the Secretary of State of the State of Minnesota is
1.20directed to prepare copies of this memorial and transmit them to the President of the United
1.21States, the President and the Secretary of the United States Senate, the Speaker and the Clerk of
1.22the United States House of Representatives, the chair of the United States Senate Committee on
2.1Finance, the chair of the United States House Committee on Ways and Means, and Minnesota's
2.2Senators and Representatives in Congress.
